These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 37513323)
1. Oligosaccharides as Potential Therapeutics against Atherosclerosis. Dabravolski SA; Sukhorukov VN; Melnichenko AA; Khotina VA; Orekhov AN Molecules; 2023 Jul; 28(14):. PubMed ID: 37513323 [TBL] [Abstract][Full Text] [Related]
2. Cyclodextrins: Potential therapeutics against atherosclerosis. Mahjoubin-Tehran M; Kovanen PT; Xu S; Jamialahmadi T; Sahebkar A Pharmacol Ther; 2020 Oct; 214():107620. PubMed ID: 32599008 [TBL] [Abstract][Full Text] [Related]
3. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Chapman MJ; Zamorano JL; Parhofer KG Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222 [TBL] [Abstract][Full Text] [Related]
4. Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander? Muhammad K; Ayoub MA; Iratni R Curr Pharm Des; 2021; 27(18):2141-2150. PubMed ID: 33461451 [TBL] [Abstract][Full Text] [Related]
5. Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis. Gong F; Wang Z; Mo R; Wang Y; Su J; Li X; Omonova CTQ; Khamis AM; Zhang Q; Dong M; Su Z J Control Release; 2022 Sep; 349():940-953. PubMed ID: 35870569 [TBL] [Abstract][Full Text] [Related]
6. High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis. Favari E; Thomas MJ; Sorci-Thomas MG J Cardiovasc Pharmacol; 2018 Jun; 71(6):325-331. PubMed ID: 29528874 [TBL] [Abstract][Full Text] [Related]
7. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325 [TBL] [Abstract][Full Text] [Related]
8. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345 [No Abstract] [Full Text] [Related]
9. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV Am J Pathol; 2016 May; 186(5):1361-74. PubMed ID: 26952642 [TBL] [Abstract][Full Text] [Related]
10. Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications. Montarello NJ; Nguyen MT; Wong DTL; Nicholls SJ; Psaltis PJ Cardiovasc Drugs Ther; 2022 Apr; 36(2):347-362. PubMed ID: 33170943 [TBL] [Abstract][Full Text] [Related]
11. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Ridker PM; Bhatt DL; Pradhan AD; Glynn RJ; MacFadyen JG; Nissen SE; Lancet; 2023 Apr; 401(10384):1293-1301. PubMed ID: 36893777 [TBL] [Abstract][Full Text] [Related]
12. The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression. Markin AM; Markina YV; Bogatyreva AI; Tolstik TV; Chakal DA; Breshenkov DG; Charchyan ER Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047399 [TBL] [Abstract][Full Text] [Related]
13. Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy. Li Y; Feng Q; Wang L; Gao X; Xi Y; Ye L; Ji J; Yang X; Zhai G J Drug Target; 2024 Dec; 32(2):128-147. PubMed ID: 38217526 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Engelen SE; Robinson AJB; Zurke YX; Monaco C Nat Rev Cardiol; 2022 Aug; 19(8):522-542. PubMed ID: 35102320 [TBL] [Abstract][Full Text] [Related]
16. Algal Polysaccharides as Therapeutic Agents for Atherosclerosis. Patil NP; Le V; Sligar AD; Mei L; Chavarria D; Yang EY; Baker AB Front Cardiovasc Med; 2018; 5():153. PubMed ID: 30417001 [TBL] [Abstract][Full Text] [Related]
17. Targeting autophagy in atherosclerosis: Advances and therapeutic potential of natural bioactive compounds from herbal medicines and natural products. Wang S; Yuan R; Liu M; Zhang Y; Jia B; Ruan J; Shen J; Zhang Y; Liu M; Wang T Biomed Pharmacother; 2022 Nov; 155():113712. PubMed ID: 36130420 [TBL] [Abstract][Full Text] [Related]
18. Novel Approaches to Anti-atherosclerotic Therapy: Cell-based Models and Herbal Preparations (Review of Our Own Data). Orekhov AN; Grechko AV; Romanenko EB; Zhang D; Chistiakov DA Curr Drug Discov Technol; 2020; 17(3):278-285. PubMed ID: 30621565 [TBL] [Abstract][Full Text] [Related]
19. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215 [TBL] [Abstract][Full Text] [Related]
20. [Basic research of fibrosis on atherosclerotic plaque stability and related drug application]. Yin J; Li Q; Zhao Z; Yang Q; Li YJ; Chen Y; Wang YJ; Weng XG; Cai WY; Zhu XX Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):235-241. PubMed ID: 30989939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]